Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Velmari
- Development stage
- Phase 4
- Lead developer
- Exeltis
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Velmari is a prolonged-release combined oral contraceptive (COC) developed by Exeltis. It contains 2 mg of dienogest, a fourth-generation progestin with potent progestogenic and antiandrogenic effects, and 0.02 mg of ethinyl estradiol, a synthetic estrogen. Unlike traditional COCs that use immediate-release formulations, Velmari utilizes a prolonged-release mechanism for its active ingredients. The drug provides contraception primarily by suppressing ovulation through the inhibition of gonadotropin secretion via the hypothalamic-pituitary-ovarian axis. It was evaluated in Phase II clinical trials for its bleeding profile and safety, and it received marketing authorization in several European markets via the Nordic MPA in early 2024.
- Brand names
- Velmari
- Other names
- Dienogest/Ethinylestradiol Exeltis 2 mg/0.02 mg prolonged-release tablet
02
Targets
AR (Adrenergic receptors)SERPINA6 (Corticosteroid-binding globulin)PR (Progesterone receptor)SHBG (Sex hormone-binding globulin)
Beyond the preview
Go deeper on Velmari.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Velmari.